John P Higgins, MD
Pathology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 2
Offices
2 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: California Pacific Medical Center- Van Ness Campus · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Higgins’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A60350 · Current
Licensed to practise in California · since 1996 · expires 2027-12-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$77,703
Medicare paid this office $77,703 for 583 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Pathology examination of tissue using a microscope, intermediate complexity | 413 | $33,579 | $32 |
| Antibody evaluation, each additional single antibody stain procedure | 51 | $10,516 | $26 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 72 | $5,556 | $74 |
| Special stained specimen slides to examine tissue, initial procedure | 132 | $5,025 | $31 |
| Special stained specimen slides to examine tissue, each additional procedure | 55 | $4,006 | $25 |
See all 15 services
| Pathology examination of tissue using a microscope, intermediate complexity | 413 | $33,579 | $32 |
| Antibody evaluation, each additional single antibody stain procedure | 51 | $10,516 | $26 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 72 | $5,556 | $74 |
| Special stained specimen slides to examine tissue, initial procedure | 132 | $5,025 | $31 |
| Special stained specimen slides to examine tissue, each additional procedure | 55 | $4,006 | $25 |
| Electron microscopy for diagnosis | 49 | $3,381 | $69 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 36 | $2,818 | $78 |
| Pathology examination of specimen during surgery, first tissue block | 27 | $2,466 | $56 |
| Special stained specimen slides to examine tissue including interpretation and report | 80 | $2,452 | $11 |
| Antibody evaluation, initial single antibody stain procedure | 51 | $1,661 | $32 |
| Microscopic genetic analysis of tumor, manual | 20 | $1,380 | $37 |
| Pathology examination of tissue using a microscope, moderately high complexity | 16 | $1,276 | $71 |
| Special stained specimen slides to examine tissue and frozen preparation of specimen including interpretation and report | 43 | $786 | $18 |
| Genetic sequencing localization, initial procedure | 18 | $693 | $39 |
| Special stained specimen slides to identify organisms including interpretation and report | 19 | $512 | $23 |
Who their Medicare patients are
583 Original Medicare patients in 2024. Average age 72 · Under 65 13% · 85 and older 7% · Women 50% · Also on Medicaid 27% · Health risk score 1.73. Above the middle of the specialty; the typical pathology clinician is at 1.55.
Conditions among them: High blood pressure 74% · Diabetes 34% · Coronary heart disease 31% · Chronic kidney disease 31% · Cancer 28% · Depression 19% · Heart failure 17% · Atrial fibrillation 16% · COPD 15% · Stroke 7% · Dementia 5%.
The office billed $983,778, Medicare allowed $98,999 and paid $77,703; for 2,432 services of 23 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 583 | 2,432 | 72 | 1.73 | $983,778 | $77,703 |
| 2023 | 361 | 1,785 | 70 | 2.11 | $637,794 | $61,481 |
| 2022 | 542 | 1,961 | 72 | 1.76 | $681,628 | $78,625 |
| 2021 | 853 | 2,955 | 71 | 1.54 | $641,956 | $112,815 |
| 2020 | 775 | 3,011 | 71 | 1.55 | $617,147 | $114,340 |
| 2019 | 600 | 2,459 | 71 | 1.67 | $485,748 | $94,635 |
| 2018 | 656 | 2,374 | 71 | 1.60 | $459,231 | $89,226 |
| 2017 | 609 | 2,124 | 71 | 1.49 | $418,780 | $83,499 |
| 2016 | 676 | 2,309 | 70 | 1.67 | $438,877 | $87,389 |
| 2015 | 793 | 2,779 | 70 | 1.68 | $538,650 | $112,482 |
| 2014 | 593 | 2,287 | 69 | 1.64 | $423,337 | $83,290 |
| 2013 | 651 | 2,394 | 69 | 1.65 | $444,079 | $93,883 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Pathology examination of tissue using a microscope, intermediate complexity | 189 | $14,197 | $35 |
| Antibody evaluation, each additional single antibody stain procedure | 54 | $11,656 | $27 |
| Pathology examination of tissue using a microscope, moderately high complexity | 63 | $6,037 | $76 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 58 | $4,597 | $78 |
| Electron microscopy for diagnosis | 53 | $3,842 | $72 |
| Special stained specimen slides to examine tissue including interpretation and report | 97 | $3,454 | $11 |
| Special stained specimen slides to examine tissue, initial procedure | 77 | $2,989 | $32 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 18 | $2,967 | $165 |
| Special stained specimen slides to examine tissue, each additional procedure | 34 | $2,770 | $26 |
| Antibody evaluation, initial single antibody stain procedure | 55 | $1,833 | $33 |
| Pathology examination of specimen during surgery, first tissue block | 20 | $1,576 | $58 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 12 | $979 | $82 |
| Special stained specimen slides to examine tissue and frozen preparation of specimen including interpretation and report | 43 | $813 | $19 |
| Microscopic genetic analysis of tumor, manual | 11 | $506 | $39 |
| Special stained specimen slides to identify organisms including interpretation and report | 13 | $444 | $25 |
2022: 18 services
| Pathology examination of tissue using a microscope, intermediate complexity | 271 | $22,492 | $34 |
| Pathology examination of tissue using a microscope, moderately high complexity | 78 | $8,931 | $76 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 112 | $8,585 | $75 |
| Pathology examination of tissue using a microscope, high complexity | 44 | $7,738 | $136 |
| Special stained specimen slides to examine tissue, each additional procedure | 64 | $6,000 | $26 |
| Antibody evaluation, each additional single antibody stain procedure | 21 | $4,608 | $27 |
| Special stained specimen slides to examine tissue, initial procedure | 113 | $4,131 | $32 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 24 | $3,949 | $165 |
| Special stained specimen slides to examine tissue including interpretation and report | 73 | $2,331 | $11 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 23 | $1,809 | $79 |
| Pathology examination of specimen during surgery, first tissue block | 13 | $1,752 | $58 |
| Electron microscopy for diagnosis | 24 | $1,738 | $72 |
| Microscopic genetic analysis of tumor, manual | 23 | $1,249 | $39 |
| Antibody evaluation, initial single antibody stain procedure | 23 | $771 | $34 |
| Genetic sequencing localization, initial procedure | 12 | $571 | $41 |
| Pathology examination of tissue using a microscope, moderately low complexity | 33 | $393 | $11 |
| Special stained specimen slides to examine tissue and frozen preparation of specimen including interpretation and report | 19 | $370 | $19 |
| Special stained specimen slides to identify organisms including interpretation and report | 11 | $344 | $25 |
2021: 13 services
| Pathology examination of tissue using a microscope, intermediate complexity | 626 | $55,222 | $35 |
| Special stained specimen slides to examine tissue, each additional procedure | 114 | $10,071 | $27 |
| Pathology examination of tissue using a microscope, moderately high complexity | 89 | $9,672 | $79 |
| Pathology examination of tissue using a microscope, high complexity | 62 | $9,254 | $140 |
| Special stained specimen slides to examine tissue, initial procedure | 217 | $8,588 | $33 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 72 | $5,811 | $77 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 40 | $3,227 | $81 |
| Pathology examination of specimen during surgery, first tissue block | 24 | $2,446 | $60 |
| Microscopic genetic analysis of tumor, manual | 39 | $1,962 | $40 |
| Special stained specimen slides to examine tissue including interpretation and report | 51 | $1,407 | $11 |
| Special stained specimen slides to identify organisms including interpretation and report | 38 | $1,194 | $25 |
| Genetic sequencing localization, initial procedure | 24 | $1,079 | $41 |
| Pathology examination of tissue using a microscope, moderately low complexity | 63 | $735 | $11 |
2020: 17 services
| Pathology examination of tissue using a microscope, intermediate complexity | 509 | $51,592 | $36 |
| Pathology examination of tissue using a microscope, moderately high complexity | 92 | $10,757 | $81 |
| Special stained specimen slides to examine tissue, each additional procedure | 99 | $9,036 | $27 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 100 | $8,235 | $82 |
| Pathology examination of tissue using a microscope, high complexity | 47 | $7,036 | $144 |
| Special stained specimen slides to examine tissue, initial procedure | 176 | $6,936 | $34 |
| Antibody evaluation, each additional single antibody stain procedure | 19 | $3,918 | $28 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 37 | $3,134 | $85 |
| Special stained specimen slides to examine tissue including interpretation and report | 80 | $2,572 | $12 |
| Pathology examination of specimen during surgery, first tissue block | 25 | $2,518 | $61 |
| Microscopic genetic analysis of tumor, manual | 31 | $1,694 | $41 |
| Electron microscopy for diagnosis | 19 | $1,429 | $75 |
| Special stained specimen slides to identify organisms including interpretation and report | 28 | $954 | $27 |
| Genetic sequencing localization, initial procedure | 18 | $810 | $43 |
| Antibody evaluation, initial single antibody stain procedure | 19 | $738 | $35 |
| Pathology examination of tissue using a microscope, moderately low complexity | 48 | $540 | $11 |
| Pathology examination of tissue using a microscope, limited examination | 11 | $47 | $4 |
2019: 17 services
| Pathology examination of tissue using a microscope, intermediate complexity | 375 | $36,215 | $36 |
| Pathology examination of tissue using a microscope, moderately high complexity | 93 | $11,337 | $79 |
| Pathology examination of tissue using a microscope, high complexity | 55 | $7,510 | $134 |
| Special stained specimen slides to examine tissue, initial procedure | 138 | $6,426 | $34 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 83 | $6,424 | $76 |
| Special stained specimen slides to examine tissue, each additional procedure | 66 | $6,147 | $28 |
| Antibody evaluation, each additional single antibody stain procedure | 28 | $5,801 | $27 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 29 | $2,412 | $83 |
| Special stained specimen slides to examine tissue including interpretation and report | 82 | $2,353 | $11 |
| Pathology examination of specimen during surgery, first tissue block | 23 | $2,120 | $61 |
| Electron microscopy for diagnosis | 27 | $1,977 | $73 |
| Microscopic genetic analysis of tumor, manual | 26 | $1,299 | $41 |
| Special stained specimen slides to identify organisms including interpretation and report | 28 | $1,042 | $25 |
| Antibody evaluation, initial single antibody stain procedure | 29 | $1,034 | $34 |
| Genetic sequencing localization, initial procedure | 16 | $754 | $42 |
| Pathology examination of tissue using a microscope, moderately low complexity | 58 | $682 | $10 |
| Special stained specimen slides to examine tissue and frozen preparation of specimen including interpretation and report | 22 | $536 | $21 |
2018: 17 services
| Pathology examination of tissue using a microscope, intermediate complexity | 455 | $40,629 | $35 |
| Special stained specimen slides to examine tissue, each additional procedure | 72 | $7,036 | $27 |
| Pathology examination of tissue using a microscope, moderately high complexity | 50 | $6,719 | $80 |
| Special stained specimen slides to examine tissue, initial procedure | 158 | $6,139 | $34 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 78 | $6,081 | $78 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 51 | $4,195 | $82 |
| Antibody evaluation, each additional single antibody stain procedure | 17 | $3,715 | $27 |
| Pathology examination of specimen during surgery, first tissue block | 20 | $3,647 | $61 |
| Pathology examination of tissue using a microscope, high complexity | 21 | $3,269 | $142 |
| Special stained specimen slides to examine tissue including interpretation and report | 61 | $1,667 | $11 |
| Microscopic genetic analysis of tumor, manual | 26 | $1,322 | $43 |
| Electron microscopy for diagnosis | 17 | $1,232 | $72 |
| Special stained specimen slides to identify organisms including interpretation and report | 28 | $871 | $24 |
| Antibody evaluation, initial single antibody stain procedure | 20 | $684 | $34 |
| Genetic sequencing localization, initial procedure | 12 | $504 | $42 |
| Pathology examination of tissue using a microscope, moderately low complexity | 16 | $188 | $10 |
| Pathology examination of tissue using a microscope, limited examination | 13 | $53 | $4 |
2017: 15 services
| Pathology examination of tissue using a microscope, intermediate complexity | 443 | $35,514 | $34 |
| Pathology examination of tissue using a microscope, moderately high complexity | 73 | $10,682 | $80 |
| Pathology examination of tissue using a microscope, high complexity | 56 | $7,855 | $140 |
| Special stained specimen slides to examine tissue, initial procedure | 147 | $5,735 | $32 |
| Special stained specimen slides to examine tissue, each additional procedure | 64 | $5,085 | $27 |
| Pathology examination of specimen during surgery, first tissue block | 36 | $4,641 | $60 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 51 | $4,119 | $79 |
| Microscopic genetic analysis of tumor, manual | 20 | $1,302 | $52 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 16 | $1,300 | $81 |
| Special stained specimen slides to examine tissue including interpretation and report | 56 | $1,261 | $11 |
| Antibody evaluation, each additional single antibody stain procedure | 11 | $1,227 | $27 |
| Special stained specimen slides to identify organisms including interpretation and report | 30 | $978 | $24 |
| Electron microscopy for diagnosis | 12 | $868 | $72 |
| Pathology examination of tissue using a microscope, moderately low complexity | 56 | $689 | $11 |
| Antibody evaluation, initial single antibody stain procedure | 12 | $414 | $35 |
2016: 15 services
| Pathology examination of tissue using a microscope, intermediate complexity | 456 | $35,264 | $34 |
| Pathology examination of tissue using a microscope, moderately high complexity | 93 | $12,178 | $78 |
| Pathology examination of tissue using a microscope, high complexity | 60 | $8,178 | $136 |
| Pathology examination of specimen during surgery, first tissue block | 48 | $5,212 | $59 |
| Special stained specimen slides to examine tissue, initial procedure | 133 | $5,072 | $33 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 66 | $4,964 | $74 |
| Antibody evaluation, each additional single antibody stain procedure | 26 | $3,806 | $23 |
| Special stained specimen slides to examine tissue, each additional procedure | 51 | $3,084 | $25 |
| Electron microscopy for diagnosis | 33 | $2,260 | $68 |
| Special stained specimen slides to examine tissue including interpretation and report | 91 | $2,002 | $11 |
| Antibody evaluation, initial single antibody stain procedure | 33 | $1,118 | $34 |
| Special stained specimen slides to identify organisms including interpretation and report | 32 | $1,107 | $25 |
| Pathology examination of tissue using a microscope, moderately low complexity | 75 | $895 | $10 |
| Preparation of tissue for examination by removing any calcium present | 16 | $235 | $12 |
| Pathology examination of tissue using a microscope, limited examination | 19 | $76 | $4 |
2015: 16 services
| Pathology examination of tissue using a microscope, intermediate complexity | 486 | $31,906 | $35 |
| Antibody evaluation, initial single antibody stain procedure | 51 | $18,028 | $39 |
| Pathology examination of tissue using a microscope, moderately high complexity | 136 | $15,473 | $78 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 134 | $10,254 | $76 |
| Pathology examination of tissue using a microscope, high complexity | 55 | $8,186 | $139 |
| Pathology examination of specimen during surgery, first tissue block | 38 | $5,149 | $59 |
| Special stained specimen slides to examine tissue, initial procedure | 140 | $4,919 | $33 |
| Electron microscopy for diagnosis | 52 | $3,706 | $71 |
| Special stained specimen slides to examine tissue including interpretation and report | 149 | $3,686 | $11 |
| Special stained specimen slides to examine tissue, each additional procedure | 56 | $2,826 | $19 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 15 | $2,422 | $161 |
| Special stained specimen slides to identify organisms including interpretation and report | 42 | $1,798 | $25 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 18 | $1,452 | $81 |
| Microscopic genetic analysis of tumor, manual | 13 | $705 | $50 |
| Pathology examination of tissue using a microscope, moderately low complexity | 58 | $701 | $11 |
| Preparation of tissue for examination by removing any calcium present | 26 | $349 | $12 |
2014: 14 services
| Pathology examination of tissue using a microscope, intermediate complexity | 379 | $25,527 | $33 |
| Antibody evaluation, initial single antibody stain procedure | 56 | $19,055 | $39 |
| Pathology examination of tissue using a microscope, moderately high complexity | 72 | $8,245 | $75 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 93 | $7,389 | $73 |
| Electron microscopy for diagnosis | 61 | $4,190 | $68 |
| Pathology examination of tissue using a microscope, high complexity | 26 | $3,765 | $134 |
| Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain | 116 | $3,500 | $28 |
| Special stained specimen slides to examine tissue including interpretation and report | 129 | $2,873 | $11 |
| Pathology examination of specimen during surgery, first tissue block | 26 | $2,316 | $55 |
| Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure) | 55 | $1,461 | $11 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 18 | $1,412 | $78 |
| Special stained specimen slides to identify organisms including interpretation and report | 30 | $1,209 | $25 |
| Genetic sequencing localization, initial procedure | 11 | $969 | $54 |
| Pathology examination of tissue using a microscope, moderately low complexity | 31 | $350 | $10 |
2013: 15 services
| Pathology examination of tissue using a microscope, intermediate complexity | 386 | $26,288 | $33 |
| Antibody evaluation, initial single antibody stain procedure | 47 | $15,068 | $38 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 109 | $10,545 | $74 |
| Pathology examination of tissue using a microscope, moderately high complexity | 103 | $9,711 | $71 |
| Special stained specimen slides to examine tissue, initial procedure | 102 | $8,391 | $38 |
| Pathology examination of tissue using a microscope, high complexity | 45 | $6,057 | $129 |
| Pathology examination of specimen during surgery, first tissue block | 42 | $5,308 | $56 |
| Electron microscopy for diagnosis | 56 | $3,635 | $65 |
| Special stained specimen slides to examine tissue including interpretation and report | 118 | $2,611 | $11 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 24 | $1,766 | $74 |
| Special stained specimen slides to identify organisms including interpretation and report | 54 | $1,573 | $23 |
| Microscopic genetic analysis of tumor, manual | 14 | $653 | $47 |
| Pathology examination of tissue using a microscope, moderately low complexity | 44 | $553 | $10 |
| Preparation of tissue for examination by removing any calcium present | 19 | $238 | $10 |
| Pathology examination of tissue using a microscope, limited examination | 20 | $74 | $4 |
Medicaid work
$29,793 in 2024
Medicaid paid $29,793 for 542 billed services this clinician did in 2024, up to 69 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| TISSUE EXAM BY PATHOLOGIST | 373 | $23,599 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 83 | $3,406 |
| Special stain including interpretation and report; Group II, all other (eg, iron, trichrome), except stain for microorganisms, stains for enzyme constituents, or immunocytochemistry and immunohistochemistry | 51 | $1,911 |
| IMHCHEM/IMCYTCHM EA ADD ANTB | 23 | $543 |
| Consultation and report on referred slides prepared elsewhere | 12 | $334 |
| 2024 | 542 | 5 | 69 | $29,793 |
| 2023 | 344 | 4 | 47 | $20,175 |
| 2022 | 277 | 4 | 42 | $15,950 |
| 2021 | 490 | 4 | 77 | $29,683 |
| 2020 | 321 | 3 | 56 | $21,841 |
| 2019 | 353 | 4 | 30 | $16,230 |
| 2018 | 352 | 3 | 49 | $20,077 |
See the largest Medicaid services in earlier years
2023
| TISSUE EXAM BY PATHOLOGIST | 118 | $6,899 |
| Special stain including interpretation and report; Group II, all other (eg, iron, trichrome), except stain for microorganisms, stains for enzyme constituents, or immunocytochemistry and immunohistochemistry | 118 | $6,834 |
| TISSUE EXAM BY PATHOLOGIST | 36 | $3,621 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 72 | $2,820 |
2022
| TISSUE EXAM BY PATHOLOGIST | 112 | $7,430 |
| Special stain including interpretation and report; Group II, all other (eg, iron, trichrome), except stain for microorganisms, stains for enzyme constituents, or immunocytochemistry and immunohistochemistry | 51 | $3,744 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 77 | $2,731 |
| TISSUE EXAM BY PATHOLOGIST | 37 | $2,045 |
2021
| TISSUE EXAM BY PATHOLOGIST | 297 | $21,327 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 138 | $4,633 |
| TISSUE EXAM BY PATHOLOGIST | 25 | $2,958 |
| TISSUE EXAM BY PATHOLOGIST | 30 | $766 |
2020
| TISSUE EXAM BY PATHOLOGIST | 248 | $18,098 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 59 | $2,737 |
| Special stain including interpretation and report; Group II, all other (eg, iron, trichrome), except stain for microorganisms, stains for enzyme constituents, or immunocytochemistry and immunohistochemistry | 14 | $1,005 |
2019
| TISSUE EXAM BY PATHOLOGIST | 200 | $11,260 |
| Special stain including interpretation and report; Group II, all other (eg, iron, trichrome), except stain for microorganisms, stains for enzyme constituents, or immunocytochemistry and immunohistochemistry | 47 | $2,313 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 90 | $2,274 |
| TISSUE EXAM BY PATHOLOGIST | 16 | $383 |
2018
| TISSUE EXAM BY PATHOLOGIST | 259 | $16,391 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 63 | $2,401 |
| Special stain including interpretation and report; Group II, all other (eg, iron, trichrome), except stain for microorganisms, stains for enzyme constituents, or immunocytochemistry and immunohistochemistry | 30 | $1,285 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1154474872
- Licence
- CA A60350California A60350: Current · expires 2027-12-31
- Trained
- Stanford University School of Medicine, 1994
- Group
- Stanford Health Care
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A603500
- Taxonomy
- Federal specialty code 207ZP0102X (207ZP0102X); Federal specialty code 207ZP0101X (207ZP0101X)
- Mailing address
- 300 Pasteur Dr Rm L235, Department of Pathology, Stanford, CA, 94305
- NPI first listed
- 2007-01-18
- NPI last updated
- 2024-03-13
- NPI record certified
- 2024-03-13
This is when the NPI record was last certified, not a medical board exam.